Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Liabilities types

An important and difficult task is concisely translating your requirements into study objectives. For example, if you need to decide between two methods of storing a hazardous chemical in a plant, the analysis objective should precisely define that what is needed is the relative difference between the methods, not the more general I want to know the risk of these two storage methods. And asking your QRA team for more than is necessary to satisfy your particular need is counterproductive and may create unnecessary liabilities. For any QRA to efficiently produce the necessary types of results, you must clearly communicate your requirements... [Pg.26]

Your process may produce wastes that cannot be treated on-site, and so must be transported off-site for treatment and disposal. Wastes of this type are usually non-aqueous liquids, sludge, or solids. Often, wastes for off-site disposal are costly to transport and to treat, and represent a third-party liability. Therefore, minimization of these wastes yields a direct cost benefit, both present and future. Measure the quantity and note the composition of any wastes associated with your process that need to be sent for off-site disposal. Record your results in a table or an appropriate spreadsheet. [Pg.376]

Type 315-This has a composition that provides a similar oxidation resistance to type 309 but has less liability to embrittlement due to sigma formation if used for long periods in the range of 425 to 815°C. (Sigma phase is the hard and brittle intermetallic compound FeCr formed in chromium rich alloys when used for long periods in the temperature range of 650 to 850°.)... [Pg.71]

Ihe implementation of the Resource Conservation and Recovery Act (RCRA) and the Comprehensive Environmental Response, Compensation, and Liability Act (Superfund) has underscored a number of the weaknesses in our capabilities to measure the chemical characteristics of wastes. We are now being called upon to identify and quantify with unprecedented sensitivity hundreds of chemicals found in many types of materials within waste sites, near discharges of hazardous contaminants, and in the surrounding environments. Extrapolations from a limited number of measurements must indicate the general environmental conditions near waste sites. The measurements have to be made faster and cheaper than ever before, with the precision and bias of each measurement fully documented. Thus, the technical challenges facing the monitoring community are substantial. [Pg.1]

Type III Costs Contingent costs Liabilities (e.g., clean up) Lawsuits Damage to resources Accidents... [Pg.235]

A potential liability associated with such reductive hydroacylations resides in the fact that only one acyl residue of the symmetric anhydride is incorporated into the coupling product. For more precious carboxylic acids, selective acyl transfer from mixed anhydrides is possible. Mixed anhydrides derived from pivalic acid are especially convenient, as they may be isolated chromato-graphically in most cases. In practice, mixed anhydrides of this type enable completely branch-selective hydroacylation with selective delivery of the aromatic and a,()-unsalurated acyl donors (Scheme 19). [Pg.107]

The partitioning of the activated inhibitor between direct covalent inactivation of the enzyme and release into solution is an important issue for mechanism-based inactivators. The partition ratio is of value as a quantitative measure of inactivation efficiency, as described above. This value is also important in assessing the suitability of a compound as a drug for clinical use. If the partition ratio is high, this means that a significant proportion of the activated inhibitor molecules is not sequestered as a covalent adduct with the target enzyme but instead is released into solution. Once released, the compound can diffuse away to covalently modify other proteins within the cell, tissue, or systemic circulation. This could then lead to the same types of potential clinical liabilities that were discussed earlier in this chapter in the context of affinity labels, and would therefore erode the potential therapeutic index for such a compound. [Pg.234]

It is not currently feasible to achieve a zero discharge of chemical pollutants from metal finishing operations. However, substantial reductions in the type and volume of hazardous chemicals wasted from most metal finishing operations are possible.8 Because end-of-pipe waste detoxification is costly for small- and medium-sized metal finishers, and the cost and liability of residuals disposal have increased for all metal finishers, management and production personnel may be more willing to consider production process modifications to reduce the amount of chemicals lost to waste. [Pg.358]

In 1980, the U.S. Congress enacted the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), the first comprehensive federal law addressing the protection of the environment from the threat of hazardous substances. The primary goal of CERCLA is to establish an organized cost-effective mechanism for response to abandoned or uncontrolled hazardous waste sites that pose a serious threat to human health and the environment.8 9 To accomplish this goal, two types of response capabilities are mandated by CERCLA13 ... [Pg.590]

Critics have long complained about the ineffectiveness of medical liability law both as a means of reducing the risks of injuries and as a system of compensation for injuries. So far, none of these critiques has led policy makers to jettison our fault-based medical liability system and to replace it with some type of no-fault system as proposed by some scholars. Thus some form of medical liability is going to be a feature of the social and regulatory... [Pg.188]

These differences in the behavioural properties of the opioid receptor sub-types are of considerable interest because the clinical use of currently marketed opioid analgesic drugs is limited by their undesirable side-effects, which include respiratory depression, constipation and an abuse or dependence liability. These side-effects have been associated with mu receptor ac-... [Pg.114]

The manufacturers of a mass product that is far from the end-user, such as cement or concrete, are under extreme price competition and slightest changes in, say, the cost stracture can be decisive. Elimination of water-soluble chrome-VI compounds that cause chromate-induced eczema would only increase the price of the product minimally. And even if the severe price competition did in fact permit this increased margin (which is highly probable in this example), there has been no significant iimovation push. Uirfortunately, this occupational disease is hardly perceived by the public and the costs incurred by this type of eczema evidently can be externalised by the cement industry (and covered by the employer s liability insurance). [Pg.114]

However, the reverse is not necessarily true all compounds that block the hERG channels do not prolong action potentials. Part of the reason lies in the fact that many compounds have a mixed effect on ion channels, particularly due to the blocking effect on both hERG and the L-type calcium channel [21], which is responsible for phase 2 of the cardiac action potential (Figure 16.1). Examples for such dual-blockers include bepridil, verapamil and mibefradil [22], all blocking hERG and L-type calcium channels at the therapeutic concentrations. However, only verapamil has nearly no cardiac liabilities. [Pg.390]

Jia, L. and Sun, H. (2008) Support vector machines classification of hERG liabilities based on atom types. Bioorganic ei Medicinal Chemistry, 16, 6252—6260. [Pg.412]


See other pages where Liabilities types is mentioned: [Pg.77]    [Pg.77]    [Pg.56]    [Pg.77]    [Pg.77]    [Pg.56]    [Pg.73]    [Pg.1121]    [Pg.144]    [Pg.171]    [Pg.286]    [Pg.289]    [Pg.290]    [Pg.353]    [Pg.518]    [Pg.31]    [Pg.148]    [Pg.163]    [Pg.164]    [Pg.438]    [Pg.648]    [Pg.283]    [Pg.36]    [Pg.206]    [Pg.89]    [Pg.104]    [Pg.117]    [Pg.15]    [Pg.267]    [Pg.298]    [Pg.124]    [Pg.18]    [Pg.19]    [Pg.41]    [Pg.73]    [Pg.2]    [Pg.356]    [Pg.68]   
See also in sourсe #XX -- [ Pg.262 ]




SEARCH



Liability

© 2024 chempedia.info